Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Current Assets (2016 - 2025)

Historic Current Assets for Macrogenics (MGNX) over the last 14 years, with Q3 2025 value amounting to $232.1 million.

  • Macrogenics' Current Assets rose 445.33% to $232.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $232.1 million, marking a year-over-year increase of 445.33%. This contributed to the annual value of $217.5 million for FY2024, which is 1346.75% down from last year.
  • Macrogenics' Current Assets amounted to $232.1 million in Q3 2025, which was up 445.33% from $204.9 million recorded in Q2 2025.
  • Macrogenics' 5-year Current Assets high stood at $374.7 million for Q1 2021, and its period low was $147.8 million during Q3 2022.
  • Its 5-year average for Current Assets is $243.0 million, with a median of $222.2 million in 2024.
  • Its Current Assets has fluctuated over the past 5 years, first crashed by 5583.72% in 2022, then skyrocketed by 9708.75% in 2023.
  • Quarter analysis of 5 years shows Macrogenics' Current Assets stood at $279.6 million in 2021, then decreased by 20.53% to $222.2 million in 2022, then rose by 13.12% to $251.3 million in 2023, then fell by 13.47% to $217.5 million in 2024, then grew by 6.71% to $232.1 million in 2025.
  • Its Current Assets was $232.1 million in Q3 2025, compared to $204.9 million in Q2 2025 and $182.1 million in Q1 2025.